{"product_id":"infanrix-hexa-jeringa-0-5ml-con-1-vacuna-hexavalente","title":"Infanrix Hexa Syringe 0.5ml with 1 (Hexavalent Vaccine)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eVaccines\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eHexavalent\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eInfanrix\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eHexavalent vaccine (DTaPHibIPVPC)\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e0.5 ml syringe\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eGlaxo Smith Kline\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eInfanrix Hexa is indicated for active immunization of infants and young children from 6 weeks of age to prevent diseases caused by the following pathogens: \n  - Diphtheria\n  - Tetanus\n  - Pertussis (whooping cough)\n  - Haemophilus influenzae type b (Hib)\n  - Poliovirus (IPV)\n  - Infections by hepatitis B strains (HBV). \n  The vaccination series should be started between 6 and 12 weeks of age, with a booster at 18 months and subsequently at 5 years of age.\n\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach 0.5 ml dose contains: \n  - Inactivated components of the bacteria causing diphtheria, tetanus, and pertussis.\n  - Hib antigens.\n  - Poliovirus type 1, 2, and 3 antigens.\n  - Hepatitis B virus antigen.\n  - Excipients: sodium chloride, disodium phosphate, monosodium phosphate, water for injection.\n\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eInfanrix Hexa is contraindicated in patients with a history of anaphylactic reaction to any of the vaccine components, as well as in those who have experienced encephalopathy of unknown origin within 7 days after a previous dose of a pertussis-containing vaccine.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eClinical evaluation is recommended before administration in patients with a history of seizures, neurological diseases, or immunodeficiencies. Vaccination should be postponed in cases of high fever or moderate to severe acute illness.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore refrigerated between 2 °C and 8 °C. Do not freeze. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Glaxo Smith Kline","offers":[{"title":"Default Title","offer_id":45848308252897,"sku":"7501064552120","price":1956.52,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/7501064552120_ac080fab-e5e4-4296-92d2-3df162d723c8.jpg?v=1744678112","url":"https:\/\/wecarepharma.mx\/en\/products\/infanrix-hexa-jeringa-0-5ml-con-1-vacuna-hexavalente","provider":"WeCare Pharma","version":"1.0","type":"link"}